Lyme Disease Clinical Trial
Official title:
Teleyoga for Lyme Disease
NCT number | NCT04867473 |
Other study ID # | 49667 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | October 1, 2021 |
Est. completion date | December 4, 2022 |
Verified date | August 2023 |
Source | Stanford University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Primary Aims: Modify an existing teleyoga intervention to use with Lyme disease (LD) patients and address the technical challenges of at-home teleyoga
Status | Completed |
Enrollment | 15 |
Est. completion date | December 4, 2022 |
Est. primary completion date | November 10, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Diagnosis of probable Lyme disease - Has not begun new pain medications or other treatments in the last month - English literacy - Wireless internet connection at home Exclusion Criteria: - Participation in another concurrent clinical trial - Back surgery within the last 12 months - Unstable, coexisting mental illness or psychiatric condition - Active, current suicidal intent or plan - Attended or practiced yoga = 1 x in the past 12 months |
Country | Name | City | State |
---|---|---|---|
United States | Stanford University | Palo Alto | California |
Lead Sponsor | Collaborator |
---|---|
Stanford University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change of Pain Score From Baseline | Scores on the Pain, Enjoyment, General Activity (PEG) Scale; with values from 0 to 10 and higher scores indicating worse outcomes | Measured at baseline and again at the end of 12 weeks of treatment | |
Secondary | Adherence to the Treatment Protocol | Percentage of participants who attend =65 percent of treatment sessions; values range from 0 percent to 100 percent with higher percentages indicative of a better outcome | at study completion, an average of 7 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01207739 -
Persistent Lyme Empiric Antibiotic Study Europe
|
Phase 4 | |
Terminated |
NCT04577053 -
PEMF Therapy to Treat Lingering Symptoms of Lyme Disease After Treatment With Antibiotics
|
N/A | |
Recruiting |
NCT04038346 -
Symptomatic Management of Lyme Arthritis
|
Phase 3 | |
Completed |
NCT01143558 -
Searching for Persistence of Infection in Lyme Disease
|
Early Phase 1 | |
Withdrawn |
NCT04318925 -
Evaluation and Follow-up of People With Tick-borne Diseases
|
||
Terminated |
NCT03581279 -
Detection of Borrelia Bacteria in Early Stage Lyme Borreliosis Using the T2Lyme Panel
|
N/A | |
Enrolling by invitation |
NCT05041595 -
Lyme Disease Diagnostic Assay - Collection of Whole Blood
|
||
Recruiting |
NCT03981874 -
Peripheral Facial Paralysis Sequelae in Lyme Disease Among Children
|
N/A | |
Recruiting |
NCT03963635 -
Novel Diagnostics for Early Lyme Disease
|
||
Terminated |
NCT03084614 -
CD8 Reactivity to Microorganisms in Blood and Breast Milk
|
||
Recruiting |
NCT04835792 -
Biomarker Study of Previously Treated Lyme Disease Volunteers in Comparison to Healthy Volunteers
|
||
Recruiting |
NCT06397794 -
Navigating Pregnancy and Parenthood With Lyme Disease
|
||
Recruiting |
NCT04148222 -
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Lyme Disease
|
||
Terminated |
NCT03201042 -
Lyme Test Indication Combinations (LyTIC) Study
|
||
Completed |
NCT01368341 -
Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice
|
Phase 4 | |
Terminated |
NCT00958139 -
Passive Prophylaxis of Lyme Disease Using Permethrin Treated Clothes
|
Phase 3 | |
Recruiting |
NCT00001539 -
A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations
|
||
Recruiting |
NCT03501407 -
Understanding Tick-borne Diseases
|
||
Completed |
NCT04422314 -
ImmuneSense Lyme Study
|
||
Recruiting |
NCT04719962 -
Direct Diagnosis of Disseminated Lyme Borreliosis.
|
N/A |